Anlon Healthcare Limited

Anlon Healthcare Limited

Anlon Healthcare Limited has submitted a Structured Digital Database (SDD) Compliance Certificate for the quarter ended September 30, 2026, as per Regulation 3(5) and 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized or rematerialized during the quarter ended September 30, 2026, to the National Stock Exchange and BSE.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on October 13, 2026, where the Board approved the proposal for raising of funds by way of issuance of warrants each convertible into equivalent number of equity shares, to promoters and non-promoter/public investors, for an aggregate amount not exceeding Rs.250,00,00,000/- (Rupees Two Hundred and Fifty Crore Only).

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about its participation in the Arihant Capital 'BHARAT CONNECT CONFERENCE RISING STARS 2026' under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed about the incorporation of its subsidiary, Anlon Healthcare Nigeria Limited, as per Regulation 30 of SEBI Listing Regulations.

Anlon Healthcare Limited

Anlon Healthcare Limited has made additional disclosures regarding the proposed share swap involving the acquisition of 44.94% equity shareholding of Apiqo Organics Private Limited and 47.41% equity shareholding of Bizotic Lifescience Private Limited.

Anlon Healthcare Limited

Anlon Healthcare Limited has responded to the Exchange's query regarding significant price movement in its securities, stating that the company is not aware of any information or event that may have a bearing on the price movement and has been complying with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited's stock price has experienced significant movement, prompting the NSE to contact the company for clarification.

Anlon Healthcare Limited

Anlon Healthcare Limited has been assigned a long-term credit rating of BWR BBB/Stable by Brickwork Ratings for its bank loan facilities of Rs. 23.60 crore. The rating is based on the company's management experience, growth in scale of operations, improved profitability margins, robust capital structure, and healthy debt-coverage metrics, but is constrained by intense market competition and regulatory compliance risks.

Anlon Healthcare Limited

Anlon Healthcare Limited has held its 13th Annual General Meeting on September 05, 2026, through video conference, where the company's financial statements for the year ended March 31, 2026, were adopted, and other business items were considered.

Anlon Healthcare Limited

Anlon Healthcare Limited has submitted the voting results of its 13th Annual General Meeting, where 11 resolutions were passed, including the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026.

Anlon Healthcare Limited

Anlon Healthcare Limited held its 13th Annual General Meeting on September 05, 2025, through video conference, where the company's financial performance and operations were discussed, and members raised questions to the board.

Anlon Healthcare Limited

Anlon Healthcare Limited has issued a corrigendum to its notice of annual general meeting (AGM) to be held on September 05, 2026, in response to observations raised by BSE and NSE regarding its in-principle application for issue and allotment of shares on a preferential basis.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication for the 13th Annual General Meeting to be held on September 05, 2026.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026, to consider and adopt audited financial statements for the financial year ended March 31, 2026, and to appoint a director and non-executive & independent director.

Anlon Healthcare Limited

Anlon Healthcare Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of IPO proceeds. The report states that there was a deviation from the objects stated in the Prospectus, but it was in line with the change of objects approved by shareholders. The company has expanded the scope of the object to include inorganic growth and upgradations.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange that Record date for the purpose of Annual General Meeting is 28-Aug-2026. The company's Board of Directors has approved several matters, including the Audited Standalone Financial Statements, appointment of a director, regularization of a Non-Executive & Independent Director, appointment of an Internal Auditor, and approval of remuneration of Cost Auditor. The company has also approved the increase in authorized share capital and the adoption of share swap agreements with Apiqo Organics Private Limited and Bizotic Lifescience Private Limited.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026. The Board considered and approved various matters, including audited financial statements, appointment of a director, regularization of another director, appointment of an internal auditor, remuneration of cost auditor, increase in authorized share capital, and adoption of share swap agreements for acquiring up to 44.94% and 47.41% shareholding in two private companies.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about a revised intimation regarding the acquisition of shares in Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, correcting the percentage of acquisition from 32.52% to 44.94% and 43.33% to 47.41% respectively.